Overview
the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.
Description
The main objective is to collect patients and then use different injection volumes of botulinum toxin intradermal injection for the treatment of rosacea erythema telangiectasia, and then to evaluate the clinical efficacy and safety of the treatment.
Eligibility
Inclusion Criteria
- Meeting the diagnostic criteria of mild to moderate erythema telangiectasis rosette acne;
- more than 18 years old;
- to obey the rules of the treatment in the study, and can be followed up for 12 weeks;
- informed consent;
Exclusion Criteria:
- Had received facial cosmetic surgery or botulinum toxin treatment within 6 months before this treatment;
- due to systemic diseases such as autoimmune diseases or menopause facial flush;
- had allergies botulinum toxin;
- pregnant or breastfeeding;
- other facial skin or oral disease therapy, including research before 4 weeks rose acne accept other treatment;
- With basic neuromuscular diseases (such as myasthenia gravis, amyotrophic lateral sclerosis, etc.);
- All landowners 4 weeks before the study whether any oral aminoglycoside drugs, benzodiazepines drugs or muscle relaxants; .Was removed during treatment observation data is not complete, incomplete treatment and patients can't take medication as prescribed.